Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: An updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011-2018 Tongtong Wang; Yuzhi Xi; Annaswamy Raji; Michael Crutchlow; Gail Fernandes; Samuel S Engel; Xiao Zhang;

Optimal ALT threshold for the automated diagnosis of MASLD: A population-based study using iLFT Jeremy Lee; Christopher J. Byrne; Paul N. Brennan; Iain MacPherson; Eleanor Dow; John F. Dillon;

Prevalence of liver fibrosis in an unselected general population with high prevalence of obesity and diabetes mellitus. Time for screening? Diego García-Compeán; Jesús Zacarías Villarreal-Pérez; Manuel Enrique de la O. Cavazos; Fernando Javier Lavalle-Gonzalez; Omar David Borjas-Almaguer; Angel Noé Del Cueto-Aguilera; José Alberto González-González; Consuelo Treviño-Garza; Lourdes Huerta-Pérez; Héctor Jesús Maldonado-Garza;